Barclays Boosts Nutrien (NYSE:NTR) Price Target to $59.00

Nutrien (NYSE:NTR) had its target price lifted by equities research analysts at Barclays from $56.00 to $59.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Barclays‘s price target points to a potential upside of 17.94% from the stock’s current price.

Other analysts also recently issued reports about the company. Scotiabank increased their price target on Nutrien from $60.00 to $62.00 and gave the stock a “sector outperform” rating in a report on Monday, February 24th. Oppenheimer started coverage on Nutrien in a report on Thursday, December 12th. They set an “outperform” rating and a $60.00 price target on the stock. UBS Group boosted their target price on shares of Nutrien from $53.00 to $54.00 and gave the company a “neutral” rating in a research report on Thursday, February 20th. Wells Fargo & Company raised their price target on shares of Nutrien from $53.00 to $56.00 and gave the stock an “equal weight” rating in a report on Friday, February 21st. Finally, Royal Bank of Canada restated an “outperform” rating and set a $60.00 price target on shares of Nutrien in a research note on Monday, February 24th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $59.94.

Nutrien Stock Up 3.2 %

Shares of NYSE NTR opened at $50.02 on Wednesday. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. Nutrien has a 1 year low of $43.70 and a 1 year high of $60.87. The firm has a market cap of $24.47 billion, a PE ratio of 36.51, a price-to-earnings-growth ratio of 1.19 and a beta of 0.81. The company has a 50 day simple moving average of $50.33 and a 200 day simple moving average of $48.52.

Nutrien (NYSE:NTR) last issued its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.09). The company had revenue of $5.08 billion during the quarter, compared to analyst estimates of $5.09 billion. Nutrien had a net margin of 2.62% and a return on equity of 6.81%. On average, research analysts forecast that Nutrien will post 3.72 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. Probity Advisors Inc. grew its position in shares of Nutrien by 16.0% during the 4th quarter. Probity Advisors Inc. now owns 25,739 shares of the company’s stock valued at $1,152,000 after purchasing an additional 3,558 shares in the last quarter. Comprehensive Money Management Services LLC bought a new stake in Nutrien in the 4th quarter worth approximately $224,000. Public Employees Retirement System of Ohio lifted its holdings in shares of Nutrien by 6.3% in the 4th quarter. Public Employees Retirement System of Ohio now owns 92,018 shares of the company’s stock worth $4,116,000 after acquiring an additional 5,420 shares during the last quarter. Burgundy Asset Management Ltd. lifted its stake in Nutrien by 36.1% in the fourth quarter. Burgundy Asset Management Ltd. now owns 130,000 shares of the company’s stock worth $5,811,000 after purchasing an additional 34,500 shares during the last quarter. Finally, Vise Technologies Inc. purchased a new stake in Nutrien during the 4th quarter valued at about $222,000. Institutional investors own 63.10% of the company’s stock.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.